---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-004227"
form_type: "8-K"
ticker: "CERS"
cik: "0001020214"
company_name: "CERUS CORP"
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:25:41.596054+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cerus reports preliminary 2022 product revenue of $162M, up 24% YoY, and guides 2023 revenue $165-170M

## Summary
- Preliminary Q4 2022 product revenue $44.0M, up 10% from Q4 2021.
- Full-year 2022 product revenue $162.0M, at top end of guidance, up 24% year-over-year.
- 2023 product revenue guidance range of $165-170M, citing macroeconomic uncertainty and FX headwinds.
- CEO Obi Greenman notes consistent commercial execution and growing demand for INTERCEPT Blood System in U.S.
- Company expects 2023 to be a bridge year with uncertainty most acute in Q1.

## SEC filing metadata
- accession: 0001193125-23-004227
- form_type: 8-K
- ticker: CERS
- cik: 0001020214
- company_name: CERUS CORP
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1020214/000119312523004227/0001193125-23-004227-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1020214/000119312523004227/d426660d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-004227
- JSON: https://secwatch.observer/filing/0001193125-23-004227.json
- Plain text: https://secwatch.observer/filing/0001193125-23-004227.txt

## Key facts
- Earnings Releases
  CERUS CORP reported the fourth quarter and fiscal year ended December 31, 2022 results: revenue $44.0 million. Guidance initiated.
  - Period: the fourth quarter and fiscal year ended December 31, 2022
  - Revenue: $44.0 million
  - Guidance: initiated
  - Result: preliminary results
  source text: Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update Preliminary Fourth Quarter and Full-Year 2022 Product Revenues of $44.0 million and $162.0 million reflecting year-over-year growth of 10% and 24%, respectively
  evidence_url: https://www.sec.gov/Archives/edgar/data/1020214/000119312523004227/0001193125-23-004227-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.